DAIC

FEBRUARY 27, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study. Jennifer Currin, Ph.D.,

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

Frontiers in Cardiovascular Medicine

DECEMBER 18, 2023

Background Cryoballoon ablation (CBA) and laser balloon ablation (LBA) are two innovative ways for the treatment of atrial fibrillation (AF). This study aimed to evaluate the efficacy and safety of cryoballoon ablation and laser balloon ablation in patients with AF. LBA presented a lower acute PVI rate per patients (CBA 97.0%

Atrial Fibrillation 64

Atrial Fibrillation Ablation Innovation Arrhythmia 64

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Background Catheter ablation (CA) for symptomatic atrial fibrillation (AF) offers the best outcomes for patients. Results Our patient cohort was older, with higher BMI, greater CHA2DS2-VASc scores, and larger left atrial sizes compared to similar previously published cohorts, while gender balance and other characteristics were similar.

Ablation 64

Ablation Atrial Fibrillation BMI Arrhythmia 64

DAIC

FEBRUARY 2, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , revealed findings from a company-funded study of real-world data. AFib is the most common type of cardiac arrhythmia and affects more than 6 million people in the United States and nearly 38 million people worldwide.2,3 In: AF Symposium.;

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

DAIC

FEBRUARY 7, 2024

CTA and the ACC recognize there is strong potential for cardiac monitoring (through Consumer Cardiovascular Technology Solutions) to help identify and screen patients with Atrial Fibrillation (AFib) and related arrhythmias to alert the right clinical groups for early support and reduction in mortality rates.

Technology 116

Technology Cardiovascular Disease Best Practices AFIB 116

DAIC

DECEMBER 22, 2023

The first procedures were performed by Dr. David Newton , Clinical Cardiac Electrophysiologist at Memorial Health University Physicians Heart Care and Dr. Andrea Natale , Executive Medical Director at T exas Cardiac Arrhythmia Institute, St. David’s Medical Center.

Atrial Fibrillation 59

Atrial Fibrillation AFIB Ablation Heart Rhythm 59

DAIC

JANUARY 18, 2024

milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heart rhythms such as atrial fibrillation (AFib). chief medical officer of Abbott's electrophysiology business.

Heart Rhythm 105

Heart Rhythm Ablation AFIB Chest Pain 105

DAIC

JULY 16, 2024

At the forefront of PowerPlugs is AFib Detection , a PowerPlug that discreetly monitors your heart rhythm every night to detect signs of Atrial Fibrillation (AFib). AFib is the most common type of irregular heart rhythm or arrhythmia. UltraSignal will help fuel more customization and innovation in health.

AFIB 103

AFIB Technology Heart Rhythm Arrhythmia 103

DAIC

DECEMBER 26, 2023

a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.

Ablation 59

Ablation Atrial Fibrillation Technology Hospital 59

CineECG

MAY 22, 2023

As ECG Excellence we are proud our CineECG technology was part of this innovation festival. Their study focuses on the issue of localizing the origin of atrial ectopic activity. If you want to learn more go to : [link] and search for CineECG The post Origin of atrial ectopic activity appeared first on ECG-Excellence.

Technology 52

Technology Atrial Fibrillation Anatomy Innovation 52

DAIC

DECEMBER 19, 2023

OSA is commonly seen in patients with arrhythmias like atrial fibrillation (AFib) and due to the variable unpredictable nature of sleep apnea symptoms, it is often untreated, leading to adverse outcomes. Peerbridge Health continues to innovate by compounding clinical utility in one simple device," said Andrea Natale, M.D.,

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). Atrial Fibrillation.

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

DAIC

OCTOBER 30, 2024

Director of Cardiac Arrhythmia Services for the Mount Sinai Health System in New York City. We will continue to fulfill our commitment to innovation, including new indications, to advance cardiovascular care and improve patient outcomes." tim.hodson Wed, 10/30/2024 - 13:42 Oct. The potential of Affera is limitless.

Ablation 52

Ablation AFIB Atrial Fibrillation Atrial Flutter 52